|
PT1741446E
(pt)
†
|
2000-01-21 |
2008-05-09 |
Novartis Pharma Ag |
Combinações incluindo inibidores da dipeptidilpeptidase-iv e agentes anti-diabéticos
|
|
ES2311117T3
(es)
*
|
2002-12-10 |
2009-02-01 |
Novartis Ag |
Combinacion de un inhibidor de dpp-iv y un compuesto ppar-alfa.
|
|
DE10300099A1
(de)
*
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Indol-Phenylsulfonamid-Derivate
|
|
DE10308351A1
(de)
|
2003-02-27 |
2004-11-25 |
Aventis Pharma Deutschland Gmbh |
1,3-substituierte Cycloalkylderivate mit sauren, meist heterocyclischen Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1638963B1
(en)
|
2003-05-20 |
2009-09-09 |
Novartis AG |
N-acyl nitrogen heterocycles as ligands of peroxisome proliferator-activated receptors
|
|
JP2009513523A
(ja)
*
|
2003-07-08 |
2009-04-02 |
ノバルティス アクチエンゲゼルシャフト |
ベンゼンスルホニルアミノ化合物およびそれらを含む医薬組成物
|
|
DE10335449A1
(de)
*
|
2003-08-02 |
2005-02-17 |
Bayer Healthcare Ag |
Bicyclische Indolinsulfonamid-Derivate
|
|
US20080125403A1
(en)
|
2004-04-02 |
2008-05-29 |
Merck & Co., Inc. |
Method of Treating Men with Metabolic and Anthropometric Disorders
|
|
FR2869904B1
(fr)
*
|
2004-05-07 |
2006-07-28 |
Fournier S A Sa Lab |
Modulateurs des recepteurs lxr
|
|
GT200500246A
(es)
*
|
2004-09-09 |
2006-04-17 |
|
Combinacion de compuestos organicos
|
|
RU2007131501A
(ru)
*
|
2005-01-18 |
2009-02-27 |
Новартис АГ (CH) |
Способы применения двойных агонистов ppar и устройств для доставки лекарственных средств, содержащих такие соединения
|
|
US7429667B2
(en)
|
2005-01-20 |
2008-09-30 |
Ardea Biosciences, Inc. |
Phenylamino isothiazole carboxamidines as MEK inhibitors
|
|
FR2886293B1
(fr)
|
2005-05-30 |
2007-08-24 |
Fournier S A Sa Lab |
Nouveaux composes de l'indoline
|
|
CA2610354C
(en)
|
2005-05-31 |
2011-03-29 |
Pfizer Inc. |
Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
|
|
WO2007008541A2
(en)
*
|
2005-07-08 |
2007-01-18 |
Kalypsys, Inc. |
Cellular cholesterol absorption modifiers
|
|
GT200600302A
(es)
*
|
2005-07-13 |
2007-03-19 |
|
Agonistas de ppara/y y procesos de preparación
|
|
PE20070335A1
(es)
|
2005-08-30 |
2007-04-21 |
Novartis Ag |
Benzimidazoles sustituidos y metodos para su preparacion
|
|
CA2626446A1
(en)
*
|
2005-11-07 |
2007-05-18 |
Irm Llc |
Compounds and compositions as ppar modulators
|
|
GB0526257D0
(en)
*
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
EP2402320A1
(en)
|
2006-03-31 |
2012-01-04 |
Novartis AG |
Anorectic agents
|
|
US7842836B2
(en)
|
2006-04-11 |
2010-11-30 |
Ardea Biosciences |
N-aryl-N'alkyl sulfamides as MEK inhibitors
|
|
AR060404A1
(es)
|
2006-04-11 |
2008-06-11 |
Novartis Ag |
Compuestos organicos utiles como inhibidores de dipeptidil-peptidasa iv
|
|
MX2008013097A
(es)
|
2006-04-18 |
2008-10-27 |
Ardea Biosciences Inc |
Piridona sulfonamidas y piridona sulfamidas como inhibidores de metiletilcetona.
|
|
AR063311A1
(es)
|
2006-10-18 |
2009-01-21 |
Novartis Ag |
Compuestos organicos
|
|
EP2527360B1
(en)
|
2007-06-04 |
2015-10-28 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
UA99731C2
(ru)
|
2007-07-30 |
2012-09-25 |
Ардеа Биосайенсис, Инк |
Кристаллические полиморфные формы n-(ариламино)сульфонамидов как ингибиторы мэк, композиция (варианты) и применение
|
|
RU2443699C2
(ru)
|
2007-09-20 |
2012-02-27 |
Айрм Ллк |
Соединения и композиции в качестве модуляторов активности gpr119
|
|
US9305735B2
(en)
|
2007-09-28 |
2016-04-05 |
Brigham Young University |
Reinforced polymer x-ray window
|
|
US20100285271A1
(en)
|
2007-09-28 |
2010-11-11 |
Davis Robert C |
Carbon nanotube assembly
|
|
US8498381B2
(en)
|
2010-10-07 |
2013-07-30 |
Moxtek, Inc. |
Polymer layer on X-ray window
|
|
EP2810951B1
(en)
|
2008-06-04 |
2017-03-15 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
EP2559455A1
(en)
|
2008-07-15 |
2013-02-20 |
Novartis AG |
Heteroaryl derivatives as DGAT1 inhibitors
|
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
US8247971B1
(en)
|
2009-03-19 |
2012-08-21 |
Moxtek, Inc. |
Resistively heated small planar filament
|
|
CN106478496A
(zh)
|
2009-03-27 |
2017-03-08 |
阿迪生物科学公司 |
作为mek抑制剂的二氢吡啶磺酰胺和二氢吡啶硫酰胺
|
|
WO2010114636A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Mount Sinai School Of Medicine Of New York University |
Compositions for treatment of alzheimer's disease
|
|
WO2011014520A2
(en)
|
2009-07-29 |
2011-02-03 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
|
CN102686579A
(zh)
|
2009-10-09 |
2012-09-19 |
Irm责任有限公司 |
作为gpr119活性调节剂的化合物和组合物
|
|
EP2491030B1
(en)
*
|
2009-10-22 |
2015-07-15 |
Fibrotech Therapeutics PTY LTD |
Fused ring analogues of anti-fibrotic agents
|
|
US8394858B2
(en)
|
2009-12-03 |
2013-03-12 |
Novartis Ag |
Cyclohexane derivatives and uses thereof
|
|
US7983394B2
(en)
|
2009-12-17 |
2011-07-19 |
Moxtek, Inc. |
Multiple wavelength X-ray source
|
|
US8697739B2
(en)
|
2010-07-29 |
2014-04-15 |
Novartis Ag |
Bicyclic acetyl-CoA carboxylase inhibitors and uses thereof
|
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
US8526574B2
(en)
|
2010-09-24 |
2013-09-03 |
Moxtek, Inc. |
Capacitor AC power coupling across high DC voltage differential
|
|
EP2625172B1
(en)
|
2010-10-07 |
2016-12-07 |
Novartis AG |
New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl]-phenyl} - cyclohexyl) -acetic acid
|
|
MX2013008192A
(es)
|
2011-01-13 |
2013-12-16 |
Novartis Ag |
Inhibidores de bace-2 para tratamiento de transtornos metabolicos.
|
|
PT2663561E
(pt)
|
2011-01-13 |
2016-06-07 |
Novartis Ag |
Derivados heterocíclicos novos e sua utilização no tratamento de distúrbios neurológicos
|
|
US8804910B1
(en)
|
2011-01-24 |
2014-08-12 |
Moxtek, Inc. |
Reduced power consumption X-ray source
|
|
US8750458B1
(en)
|
2011-02-17 |
2014-06-10 |
Moxtek, Inc. |
Cold electron number amplifier
|
|
US8929515B2
(en)
|
2011-02-23 |
2015-01-06 |
Moxtek, Inc. |
Multiple-size support for X-ray window
|
|
US8792619B2
(en)
|
2011-03-30 |
2014-07-29 |
Moxtek, Inc. |
X-ray tube with semiconductor coating
|
|
KR20140019834A
(ko)
|
2011-04-14 |
2014-02-17 |
노파르티스 아게 |
글리코시드 유도체 및 그의 용도
|
|
US8614195B2
(en)
|
2011-04-14 |
2013-12-24 |
Novartis Ag |
Glycoside derivatives and uses thereof
|
|
US8989354B2
(en)
|
2011-05-16 |
2015-03-24 |
Brigham Young University |
Carbon composite support structure
|
|
US9076628B2
(en)
|
2011-05-16 |
2015-07-07 |
Brigham Young University |
Variable radius taper x-ray window support structure
|
|
US9174412B2
(en)
|
2011-05-16 |
2015-11-03 |
Brigham Young University |
High strength carbon fiber composite wafers for microfabrication
|
|
CN103764635B
(zh)
|
2011-07-08 |
2016-01-20 |
诺华股份有限公司 |
新的三氟甲基-噁二唑衍生物及其在疾病治疗中的用途
|
|
UY34278A
(es)
|
2011-08-25 |
2013-04-05 |
Novartis Ag |
Derivados novedosos de oxazina y su uso en el tratamiento de enfermedades
|
|
US9187439B2
(en)
|
2011-09-21 |
2015-11-17 |
Inception Orion, Inc. |
Tricyclic compounds useful as neurogenic and neuroprotective agents
|
|
CA2851445A1
(en)
|
2011-10-13 |
2013-04-18 |
Novartis Ag |
Novel oxazine derivatives and their use in the treatment of disease
|
|
CA2856334A1
(en)
|
2011-11-28 |
2013-06-06 |
Christina Hebach |
Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
|
|
WO2013082106A1
(en)
|
2011-12-02 |
2013-06-06 |
The General Hospital Corporation |
Differentiation into brown adipocytes
|
|
US8761344B2
(en)
|
2011-12-29 |
2014-06-24 |
Moxtek, Inc. |
Small x-ray tube with electron beam control optics
|
|
SG11201406526WA
(en)
|
2012-04-27 |
2014-11-27 |
Novartis Ag |
Cyclic bridgehead ether dgat1 inhibitors
|
|
WO2013163508A1
(en)
|
2012-04-27 |
2013-10-31 |
Novartis Ag |
Tetrahydropyran dgat1 inhibitors
|
|
WO2014052619A1
(en)
|
2012-09-27 |
2014-04-03 |
Irm Llc |
Piperidine derivatives and compositions as modulators of gpr119 activity
|
|
EP2943488B1
(en)
|
2013-01-11 |
2018-03-28 |
Novartis AG |
Meglumine salt forms of 2-((1 r,4r)-4-(4-(5-(benzoxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl) acetic acid and their use as dgat1 inhibitors
|
|
US9173623B2
(en)
|
2013-04-19 |
2015-11-03 |
Samuel Soonho Lee |
X-ray tube and receiver inside mouth
|
|
SI3004138T1
(sl)
|
2013-06-05 |
2024-07-31 |
Bausch Health Ireland Limited |
Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
|
|
US10588980B2
(en)
|
2014-06-23 |
2020-03-17 |
Novartis Ag |
Fatty acids and their use in conjugation to biomolecules
|
|
EP3157947A1
(en)
|
2014-06-23 |
2017-04-26 |
Novartis AG |
Hsa-gdf-15 fusion polypeptide and use thereof
|
|
CN108367053A
(zh)
|
2015-12-22 |
2018-08-03 |
诺华股份有限公司 |
使用生长分化因子15(gdf-15)治疗或改善代谢性疾病的方法
|
|
EP3437651A1
(en)
|
2017-08-03 |
2019-02-06 |
Université de Strasbourg |
Peptides for treatment and prevention of nonalcoholic fatty liver disease
|
|
HRP20260171T1
(hr)
|
2017-12-14 |
2026-04-24 |
Université De Strasbourg |
Peptidi za liječenje i prevenciju bolesti nealkoholne masne jetre
|
|
US20230089867A1
(en)
|
2018-11-27 |
2023-03-23 |
Novartis Ag |
Cyclic pentamer compounds as proprotein convertase subtilisin/kexin type 9 (pcsk9) inhibitors for the treatment of metabolic disorder
|
|
UY38485A
(es)
|
2018-11-27 |
2020-06-30 |
Novartis Ag |
Compuestos tetrámeros cíclicos como inhibidores de proproteína convertasa subtilisina/kexina tipo 9 (pcsk9), método de tratamiento, uso y su preparación
|
|
JP7657151B2
(ja)
|
2018-11-27 |
2025-04-04 |
ノバルティス アーゲー |
代謝性障害の処置のためのプロタンパク質コンバターゼスブチリシン／ケキシン９型（ｐｃｓｋ９）阻害剤としての環状ペプチド
|
|
AU2019408382B2
(en)
|
2018-12-21 |
2024-09-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Peptides for treatment and prevention of diabetes and associated disorders
|
|
WO2022219495A1
(en)
|
2021-04-12 |
2022-10-20 |
Novartis Ag |
2-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesity
|
|
WO2023084449A1
(en)
|
2021-11-12 |
2023-05-19 |
Novartis Ag |
Diaminocyclopentylpyridine derivatives for the treatment of a disease or disorder
|
|
EP4476212A1
(en)
|
2022-02-10 |
2024-12-18 |
Novartis AG |
2-((4-((s)-2-(4-chloro-2-fluorophenyl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((s)-oxetan-2-yl)methyl)-1h-imidazole derivatives as activators of the glp1 receptor for the treatment of obesity
|